| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.015 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |